Organon Korea, Janssen Korea co-promote oral antidepressant Remeron SolTab
Published: 2004-07-05 06:58:00
Updated: 2004-07-05 06:58:00
Organon Korea said that it has contracted with Janssen Korea to co-promote in Korea Remeron SolTab (mirtazapine), an orally disintegrating tablet that has been approved for the treatment of depression. It was developed by Organon in 2001.
Unlike other antidepressant tablets, which must be swal...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
